The company owes its success during this quarter to the foreign markets, particularly the European market, which grew by 17 percent, and the Asia Pacific market, which grew by 19 percent. By contrast, the American market remained flat during the third quarter.
For the American market, net sales from the company’s knee segment decreased by 4 percent while hip sales were flat. Among the European and Asian Pacific market, hip and knee net sales both grew by double-digits.
Overall, net sales from the company’s spine segment were decreased by 2 percent; extremities sales and trauma sales increased by 7 and 19 percent respectively.
Related Articles on Orthopedic Device Companies:
Spineology to Unveil Threshold Pedicular Fixation System
Arthrosurface Launches First Ankle Resurfacing System
Wright Medical Group Names Julie Tracy Senior Vice President, Chief Communications Officer
